Clinical improvement of adrenoleukodystrophy following intravenous gammaglobulin therapy.

Miike, T; Taku, K; Tamura, T; Ohta, J; Ozaki, M; Yamamoto, C; Sakai, T; Antoku, Y; Yadomi, C

Miike, T; Taku, K; Tamura, T; Ohta, J; Ozaki, M; Yamamoto, C; Sakai, T; Antoku, Y; Yadomi, C.

Affiliation

Miike T; Department of Child Development, Kumamoto University Medical School, Japan.

Brain Dev ; 11(2): 134-7, 1989.

Article in En | MEDLINE | ID: mdl-2469340

ABSTRACT

A patient with adrenoleukodystrophy was successfully treated by means of intravenous gammaglobulin injections. The clinical symptoms, especially visual loss, were apparently relieved and no neurological deterioration was observed during a 18-month period following the start of the gammaglobulin treatment.

Subject(s)

Adrenoleukodystrophy/immunology; Diffuse Cerebral Sclerosis of Schilder/immunology; gamma-Globulins/therapeutic use; Adolescent; Adrenoleukodystrophy/diagnostic imaging; Adrenoleukodystrophy/drug therapy; Erythrocytes/cytology; Erythrocytes/metabolism; Fatty Acids/metabolism; Fibroblasts/cytology; Fibroblasts/metabolism; Humans; Injections, Intravenous; Male; Tomography, X-Ray Computed; gamma-Globulins/administration & dosage

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Gamma-Globulins / Diffuse Cerebral Sclerosis of Schilder / Adrenoleukodystrophy Limits: Adolescent / Humans / Male Language: En Journal: Brain Dev Year: 1989 Document type: Article Affiliation country: Japan Country of publication: Netherlands

Search on Google

Add to My VHL

XML

PubMed Links